Evidence map›Paper›PMID 30670452›Full record

ArticleBMJ (Clinical research ed.)2019

Multidrug resistant enteric fever in South Asia: unmet medical needs and opportunities.

Christopher M Parry, Isabela Ribeiro, Kamini Walia, Priscilla Rupali, Stephen Baker, Buddha Basnyat

Abstract read
In one paragraph

Article in BMJ (Clinical research ed.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Emergence of carbapenem-resistantFrontiers in microbiology · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. The Prevalence of Multi-Drug ResistantMicrobiology insights · 2023
    Article
  13. Article
  14. Review
  15. Engineering a Novel Bivalent Oral Vaccine against Enteric Fever.International journal of molecular sciences · 2021
    Article
  16. Article
  17. Enteric fever.BMJ (Clinical research ed.) · 2021
    Article
  18. Article
  19. Review
  20. Antimicrobial Resistance in Typhoidal Salmonella: Surveillance for Enteric Fever in Asia Project, 2016-2019.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christopher M ParryDepartment of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK christopher.parry@lstmed.ac.uk.
Isabela RibeiroDynamic Portfolio Unit, Drugs for Neglected Diseases initiative, Geneva, Switzerland.
Kamini WaliaDepartment of Medical Microbiology, Institute of Medical Education and Research, Chandigarh, India.
Priscilla RupaliDepartment of Medicine, Christian Medical College, Vellore, India.
Stephen BakerWellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Buddha BasnyatCentre for Tropical Medicine and Global Health, Oxford University, Oxford, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Resistance, Multiple, BacterialAnti-Bacterial AgentsHumansNeeds AssessmentTyphoid FeverTyphoid-Paratyphoid VaccinesAnti-Bacterial AgentsTyphoid-Paratyphoid Vaccines

Identifiers

PMID30670452
PMCPMC6340381

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.